# Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-and-safety-of-dapagliflozin-in-patients-with-inadequately-controlled/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Paresh Dandona,Chantal Mathieu,Moshe Phillip,Lars Hansen,Steven C. Griffen,Diethelm Tschöpe,Fredrik Thorén,John Xu,Anna Maria Langkilde,Joseph Proietto,Stephen Stranks,Roger Chen,David N. O’Neal,Alexia Pape,Mark Forbes,Claire Morbey,Anton Luger,Ursula Hanusch,Christoph Schnack,Evelyn Fliesser-Goerzer,Bertram Hoelzl,Christoph Ebenbichler,Rudolf Prager,Luc Van Gaal,Chris Vercammen,André Scheen,Chantal Mathieu,Francis Duyck,Frank Nobels,Johannes Ruige,Naresh Aggarwal,Vincent Woo,Bruno St-Pierre,R Dumas,Irene Hramiak,Thomas G. Elliott,Troels Krarup Hansen,Jan Erik Henriksen,Jeppe Gram,Aina S. Lihn,Jens Meldgaard Bruun,Juha Saltevo,Jyrki Taurio,Jorma Strand,Timo T. Valle,Sakari Nieminen,Kirsi H. Pietiläinen,Bruno Guerci,Samy Hadjadj,Bertrand Cariou,Bruno Vergès,Sophie Borot,Alfred Penfornis,Thomas Schaum,Diethelm Tschoepe,Cornelia Marck,Thomas Horacek,Ludger Rose,Gerhard Klausmann,Joerg Luedemann,Steffi Appelt,Ulrich Aigner,R Goebel,Thomas Behnke,Anette‐Gabriele Ziegler,Eva Péterfai,Zsuzsanna Kerenyi,Tamás Oroszlán,G Kiss,L. Könyves,Gyorgyi Piros,Moshe Phillip,Ofri Mosenzon,Naim Shehadeh,Faiad Adawi,Julio Wainstein,Francesco Dotta,PierMarco Piatti,Stefano Genovese,Agostino Consoli,Paolo Di Bartolo,Edoardo Mannucci,Carla Giordano,Annunziata Lapolla,Carlos Aguilar,Alberto Esteban,Bazzoni Ruiz,Guillermo Mondragon Ramirez,Emilia Pelayo Orozco,Carlos Alejandro,Stobschinski de Alba,Carlos Medina Pech,Jose Garza Ruiz,Leobardo Sauque Reyna,Guillermo Llamas Esperón,Luis Alejandro Nevarez Ruiz,Maricela Vidrio Velázquez,Fernando Flores Lozano,José Gerardo González‐González,Pedro Alberto García-Hernández |
| Citations | 295 |
| DOI | 10.1016/s2213-8587(17)30308-x |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | http://www.thelancet.com/article/S221385871730308X/pdf |
| OpenAlex ID | https://openalex.org/W2756104796 |
| PMID | 28919061 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Edoardo Mannucci](https://scholariq.org/researchers/edoardo-mannucci/)
- [Ofri Mosenzon](https://scholariq.org/researchers/ofri-mosenzon/)
- [Samy Hadjadj](https://scholariq.org/researchers/samy-hadjadj/)
- [Robert S. Busch](https://scholariq.org/researchers/robert-s-busch/)

## Paper journal

- [The Lancet Diabetes & Endocrinology](https://scholariq.org/journals/the-lancet-diabetes-and-endocrinology/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.